Mkts

BioXcel Therapeutics, Inc.

NASDAQ: BTAI
$0.01+0.00 (-12.00%)
As of Nov 4, 7:00 PM ET

Key statistics

52-week range
0.012.33
Today
Open0.01
Previous close0.01
Volume153.6K
Valuation
Market cap394.4K
P/E ratio—
EPS (TTM)-3.78
Income & risk
Dividend / yield—
Beta0.52
Avg volume4.62M
Discussion

BTAI News

Stories mentioning BTAI from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue206.00256.0098.00120.00168.00366.00214.001,104
Cost of Goods Sold283.0032.0011.00107.0014.00831.001,17062.00
Gross Profit(77.00)224.0087.0013.00154.00(465.00)(956.00)1,042
Operating Expenses
Research & Development2,9556,7018,74010,2564,5545,9015,1018,032
Sales General & Admin7,1913,8055,3815,6095,6994,0957,6839,450
Total Operating Expenses
Operating Income (Loss)(10,223)(10,282)(14,228)(15,852)(10,099)(10,493)(15,293)(17,296)
Interest Income211.00321.00236.00230.00279.00368.00616.00671.00
Interest Expense
Other Expense1,5191,812(12,546)657.006,5593,2984,81712,026
Pretax Income
Tax Provision
Net Income (Loss)(12,691)(12,545)(30,911)(19,187)(7,254)(10,859)(13,650)(8,299)
Earnings Per Share (Basic)(0.54)(1.03)(2.18)(2.45)(1.50)(4.28)(5.15)(3.30)
Earnings Per Share (Diluted)(0.54)(1.03)(2.18)(2.45)(1.50)(4.28)(5.15)(3.30)
Weighted Average Shares Outstanding (Basic)23,57112,20814,1967,8434,8342,5352,6492,516
Weighted Average Shares Outstanding (Diluted)23,57112,20814,1967,8434,8342,5352,6492,516

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About BTAI

BioXcel Therapeutics, Inc. (NASDAQ: BTAI) is a stock listed on the Nasdaq Stock Market under the ticker symbol BTAI. It last traded at $0.0100 (Nov 4, 2026, 7:00 PM ET), down 12.0% on the day. That gives BioXcel Therapeutics a market capitalisation of $394.4K.

Over the past 52 weeks BTAI has traded between $0.0100 and $2.33.

Revenue for the quarter ended Mar 31, 2026 was $206.0K; a net loss of $12.7M. Revenue was up 22.6% from $168.0K in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$206.0K-$12.7M-6160.7%
Dec 31, 2025$256.0K-$12.5M-4900.4%
Sep 30, 2025$98.0K-$30.9M-31541.8%
Jun 30, 2025$120.0K-$19.2M-15989.2%

From BioXcel Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…